Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation

Conditions:   Relapsed AML;   T(8;21);   C-KIT Mutation Intervention:   Drug: Dasatinib Sponsor:   Institute of Hematology & Blood Diseases Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials